IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Zivo Bioscience Inc

CUSIP: 98978N101 | 10 institutional holders

Quarters

Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13D/AMark E. Strome
with Strome Group, Inc., Strome Investment Management, LP, Strome Mezzanine Fund II, LP, +1 more
472,94212.1%New 5%+ stakeDec 31, 2025No 13F filer matched
13D/AMark E. Strome472,942
12.1% of class · Dec 31, 2025New 5%+ stake
with Strome Group, Inc., Strome Investment Management, LP, Strome Mezzanine Fund II, LP, +1 more
No 13F filer matched

Institutional Holders — Q3 2023

Schechter Investment Advisors, LLC21,900
0.0% of portfolio›$28.5K
Column Capital Advisors, LLC12,000
0.0% of portfolio›$15.6K
StyleTurnoverLocationFiled
Schechter Investment Advisors, LLC
21,900$28.5K0.0%GrowthLowBirmingham, MI2023-11-06
Column Capital Advisors, LLC
12,000$15.6K0.0%N/AN/AIndianapolis, IN2023-11-03